Vioxx Information
Vioxx information on potential side effects was not fully known at the time Vioxx arthritis drug was received FDA approval in May 1999. Although Vioxx information on more common side effects such as heartburn, vomiting, upset stomach, and other events were recognized, more Vioxx information would come to light. Soon, Vioxx information was showing that the arthritis drug carried risk of serious cardiac events. Researchers provided Vioxx information showing the likelihood of suffering a heart attack was four times the risk than if using an older arthritis pain reliever.
In addition to Vioxx information linking the drug to serious cardiovascular thromboembolic adverse events, such as heart attacks, angina pectoris, and peripheral vascular events, more Vioxx information was reported in 2002. A March 2002 FDA Vioxx information report linked Vioxx to several instances of nonbacterial meningitis. With all the Vioxx information available, linking the arthritis drug to instances of serious, life-threatening side effects every individual should be thoroughly evaluated prior to determining if Vioxx may be suitable.
Top of Page |
